Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Brent

Showing results (291-300 of 299) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 299 results.
Journal of the American College of Cardiology|December 11, 2007
Noninvasive risk assessment early after a myocardial infarction the REFINE studyDerek V Exner, Katherine M Kavanagh, Michael P Slawnych, et al.
Circulation|March 10, 2004
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyScott D Corley, Andrew E Epstein, John P DiMarco, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The Canadian Journal of Cardiology|November 9, 2018
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationJason G Andrade, Atul Verma, L Brent Mitchell, et al.
The Canadian Journal of Cardiology|February 15, 2019
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial FibrillationHanna Lee, Mary K Tan, Andrew T Yan, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|November 16, 2020
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial FibrillationJason G Andrade, Martin Aguilar, Clare Atzema, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
Pageof 30

Showing results (291-300 of 299) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 299 results.
Journal of the American College of Cardiology|December 11, 2007
Noninvasive risk assessment early after a myocardial infarction the REFINE studyDerek V Exner, Katherine M Kavanagh, Michael P Slawnych, et al.
Circulation|March 10, 2004
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) StudyScott D Corley, Andrew E Epstein, John P DiMarco, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
The Canadian Journal of Cardiology|November 9, 2018
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationJason G Andrade, Atul Verma, L Brent Mitchell, et al.
The Canadian Journal of Cardiology|February 15, 2019
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial FibrillationHanna Lee, Mary K Tan, Andrew T Yan, et al.
Journal of the American College of Cardiology|August 4, 2018
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID TrialWojciech Zareba, James P Daubert, Christopher A Beck, et al.
The American Journal of Cardiology|July 2, 2017
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF)Alexandra Silberberg, Mary K Tan, Andrew T Yan, et al.
The Canadian Journal of Cardiology|November 16, 2020
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial FibrillationJason G Andrade, Martin Aguilar, Clare Atzema, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
Pageof 30